NorthWest Biotherapeutics Inc (NWBO): Flipper or anyone else, do you think NWB...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

NorthWest Biotherapeutics Inc (NWBO)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	35
Posts	683
Boards Moderated	0
Alias Born	06/14/2012

Re: flipper44 post# 59741

Tuesday, 04/26/2016 12:12:09 PM

Tuesday, April 26, 2016 12:12:09 PM

Flipper or anyone else, do you think NWBO screening halt has to do with the relatively new information on subtypes and now t cell levels? Maybe they want to take into account this information. Would NWBO want to formally add to the trial design that they intend to consider these new filters before an interim analysis for efficacy? Would they also need or want to increase the trial size?

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NWBO News

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments • AllPennyStocks.com • 01/13/2025 01:56:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2024 10:07:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:29:14 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM

More NWBO News

InvestorsHub NewsWire

FEATURED LaFleur Minerals Provides Updates on Exploration at Swanson Gold Deposit and Plans to Restart of Beacon Gold Mill • Jan 27, 2025 9:47 AM

Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform • AVAI • Jan 27, 2025 8:00 AM

$BEOLF: Will Beyond Oil Skyrocket Monday? Multi-Million Dollar U.S. Deal Backed by Trump Advisor Aiming to Implement them as a US Standard • RKLB • Jan 27, 2025 7:10 AM

Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing • BLO • Jan 24, 2025 8:49 AM

UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM

Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow